How can anti-CD20 monoclonal antibodies be used to fight the malignant cells of Non-Hodgkin's lymphoma if both healthy and cancerous B cells possess CD20 on their surfaces?
A) The monoclonal antibodies have a higher affinity for binding the malignant B cells, allowing them to be selectively eliminated.
B) Both groups of B cells are destroyed by the monoclonal antibodies, but host damage is minimal as stem cells are unaffected and quickly generate more healthy B cells.
C) The monoclonal antibodies preferentially bind and destroy the stem cells responsible for producing the malignant B cells.
D) The monoclonal antibodies effectively eliminate malignant and healthy B cells, but the host is not negatively affected because their level of T cells increases to compensate for the lost B cells.
Correct Answer:
Verified
Q25: During a major medical crisis like the
Q26: Potential immunization strategies for the safe, rapid
Q27: Immunoassays _. (Select all that apply)
A) can
Q28: Monoclonal antibodies are _. (Select all that
Q29: Indicate the correct order of steps for
Q31: Precipitation reactions _. (Select all that apply)
A)
Q32: Determine the titer for the results of
Q33: What type of agglutination reaction is demonstrated
Q34: ABO blood typing is determined by performing
Q35: Neutralization _. (Select all that apply)
A) is
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents